VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener

Candel Therapeutics, Inc. (CADL) Total Return Calculator with Dividends Reinvested

Candel Therapeutics, Inc.

Popular:

The total return for Candel Therapeutics, Inc. (CADL) stock is +71.59% over the past 12 months. So far it's up 43.20% this year. The 5-year total return is +11.29%, meaning $10,000 invested in CADL stock 5 years ago would be worth $11,129 today. Total return includes price appreciation plus reinvesting any dividends paid out.

If you invested $10,000 in CADL 1 year ago, it would be worth $16,366 today — you'd have gained $6,366.

With Dividends Reinvested$16,366+63.66%

Price Only (No DRIP)$16,366+63.66%

Period2025-05-08 → 2026-05-07

Price

Total Return (DRIP)

S&P 500

If You Invested $10,000 in CADL

1Y$17,159+$7,159 (+71.6%)71.6% CAGR

3Y$47,500+$37,500 (+375.0%)68.1% CAGR

5Y$11,129+$1,129 (+11.3%)2.2% CAGR

10Y$11,129+$1,129 (+11.3%)1.1% CAGR

15Y$11,129+$1,129 (+11.3%)0.7% CAGR

20Y$11,129+$1,129 (+11.3%)0.5% CAGR

30Y$11,129+$1,129 (+11.3%)0.4% CAGR

Candel Therapeutics, Inc. did not pay dividends during this period. Total return = price return.

Loading CADL total return...

As of 2026-05-08

Returns at a Glance

Period	Total Return	CAGR	Price Only	Div. Contrib.	$10K →
YTD	+43.20%	—	+43.20%	—	$14,320
1Y	+71.59%	71.59%	+71.59%	—	$17,159
3Y	+375.00%	68.10%	+375.00%	—	$47,500
5Y	+11.29%	2.16%	+11.29%	—	$11,129
10Y	+11.29%	1.07%	+11.29%	—	$11,129
15Y	+11.29%	0.72%	+11.29%	—	$11,129
20Y	+11.29%	0.54%	+11.29%	—	$11,129
30Y	+11.29%	0.36%	+11.29%	—	$11,129

Risk & Highlights

Best Year+498.62%2024

Worst Year-77.63%2022

Max Drawdown-37.04%2025-07-25 → 2025-11-19 · Recovered 2026-04-20

Annual Returns

Year	Total Return	Price Return	Div.	S&P 500	vs S&P
2026YTD	-3.49%	-3.49%	—	+0.41%	-3.9pp
2025	-37.15%	-37.15%	—	+16.64%	-53.8pp
2024	+498.62%	+498.62%	—	+24.00%	+474.6pp
2023	-16.95%	-16.95%	—	+24.81%	-41.8pp
2022	-77.63%	-77.63%	—	-19.95%	-57.7pp

CADL outperformed the S&P 500 by 41.21pp over the past year (+71.59% vs +30.37%).

Loading summary...

CADL Peers' Total Return

Accurate peer set · 10 comparable names

Name	Mkt Cap	30D Rtn	YTD Total Rtn	1Y Total Rtn	Div Contrib	3Y Total Rtn	5Y Total Rtn	10Y Total Rtn
CADLCandel Therapeutics, Inc.	$429M	+57.4%	+43.2%	+71.6%	—	+375.0%	+11.3%	+11.3%
IMVTImmunovant, Inc.	$5.5B	+10.6%	+5.1%	+96.1%	—	+40.9%	+62.4%	+173.6%
IMCRImmunocore Holdings plc	$1.6B	-4.2%	-9.4%	+2.3%	—	-48.9%	-24.0%	-29.1%
IOVAIovance Biotherapeutics, Inc.	$1.3B	+6.9%	+40.9%	+13.4%	—	-49.9%	-87.6%	-34.3%
FATEFate Therapeutics, Inc.	$280M	+111.3%	+145.5%	+143.0%	—	-55.4%	-96.8%	+40.5%
NKTRNektar Therapeutics	$1.7B	+9.4%	+92.0%	+818.2%	—	+621.8%	-72.3%	-59.1%
ADCTADC Therapeutics S.A.	$478M	+1.1%	+6.8%	+196.1%	—	+77.4%	-84.1%	-87.3%
CLDXCelldex Therapeutics, Inc.	$2.2B	+6.3%	+23.4%	+76.2%	—	-0.1%	+22.0%	-43.3%
NVAXNovavax, Inc.	$1.5B	+15.7%	+29.5%	+55.1%	—	+23.9%	-94.8%	-90.4%
CRSPCRISPR Therapeutics AG	$5.1B	+5.5%	-2.5%	+53.1%	—	-6.3%	-51.3%	+272.0%
BEAMBeam Therapeutics Inc.	$3.2B	+28.5%	+16.0%	+93.9%	—	-5.6%	-55.6%	+67.8%

Compare:CADL vs IMVT CADL vs IMCR CADL vs IOVA CADL vs IMVT vs IMCR

About CADL Dividend Returns

Candel Therapeutics, Inc. (CADL) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends.

How We Calculate Total Return

Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.

Frequently Asked Questions

Q1What is the total return of CADL over the past year?

Candel Therapeutics, Inc. (CADL) delivered a return of 71.59% over the past year. Since CADL does not currently pay dividends, the total return equals the price-only return.

Q2How much would $10,000 invested in CADL be worth today?

A $10,000 investment in Candel Therapeutics, Inc. one year ago would be worth $17,159 today, representing a gain of $7,159.

Q3Does CADL pay dividends?

Candel Therapeutics, Inc. (CADL) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For CADL, the total return equals the price-only return.

Q4Did CADL beat the S&P 500?

Yes, Candel Therapeutics, Inc. (CADL) outperformed the S&P 500 by 41.21 percentage points over the past year. CADL delivered a total return of 71.59%, compared to the S&P 500's 30.37%. This 41.21pp alpha means investors in CADL earned more than a passive S&P 500 index fund.

Q5What is CADL's worst drawdown?

Candel Therapeutics, Inc. (CADL) experienced a maximum drawdown of -37.04% over the past year, declining from its peak on 2025-07-25 to its trough on 2025-11-19. The stock recovered to its prior peak by 2026-04-20. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Q6What is CADL's long-term total return over 10, 20, or 30 years?

Here are Candel Therapeutics, Inc. (CADL)'s long-term returns with dividends reinvested. Over 10 years, the total return is 11.3% (1.1% CAGR) — $10,000 would have grown to $11,129. Over 20 years: 11.3% total return (0.5% CAGR) — $10,000 → $11,129. Over 30 years: 11.3% total return (0.4% CAGR) — $10,000 → $11,129. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

Q7What was CADL's best and worst year?

Candel Therapeutics, Inc.'s best calendar year was 2024 with a total return of 498.6%. Its worst year was 2022 with a total return of -77.6%. This range shows the volatility investors should expect — the difference between the best and worst year is 576.2 percentage points.